Leveraging Roundtrip, the single touchpoint for medical transportation, to eliminate transportation as a barrier to care for specialized patient populations such as those with opioid use disorder.
利用医疗运输的单一接触点往返,消除交通作为护理特殊患者群体(例如阿片类药物使用障碍患者)的障碍。
基本信息
- 批准号:10013780
- 负责人:
- 金额:$ 25.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2021-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdherenceAdoptionAffectAlcohol or Other Drugs useAmbulancesAmbulatory CareAppointmentBackBehavioralBooksCaregiversCaringCharacteristicsClientClinicalCommunitiesComputer softwareCountryDataData CollectionDrug AddictionDrug Metabolic DetoxicationDrug usageEducationEmergency department visitEnrollmentFeedbackFinancial HardshipGoalsGrantHealthHealth ExpendituresHealth Insurance Portability and Accountability ActHealth PersonnelHealth Services AccessibilityHealth systemHealthcareHealthcare SystemsIndividualIndustryInpatientsInsurance CarriersLogisticsMeasurementMeasuresMedicalMedicineModelingOutcomePatient-Focused OutcomesPatientsPennsylvaniaPharmacotherapyPhasePovertyProcessProviderRecoveryRegulationReportingResearchResearch DesignResearch Project GrantsResourcesRiskRoleServicesSocial isolationTechnologyTestingTimeTrainingTransportationTreatment EffectivenessUnited States National Institutes of HealthUniversitiesUrsidae FamilyVisitVulnerable PopulationsWheelchairsaddictionbarrier to carebasebehavioral healthcohortdesigndigitaldrug use screeningfood insecurityhealth care availabilityhealth care service organizationhigh riskinnovationmedical appointmentmedication-assisted treatmentopioid useopioid use disorderoutpatient programspatient engagementpatient populationphase 2 studypopulation healthprogramsracial discriminationrecruitscreeningsocial determinantssocial health determinantssuccesstreatment programwillingness
项目摘要
ABSTRACT
Roundtrip’s transportation software platform is a turnkey solution that addresses transportation as a social
determinant of health by offering a single touchpoint for any healthcare organization to coordinate all levels of
non-emergency transportation (rideshare, medical sedan, wheelchair van, non-emergency ambulance) for
specialized patient populations. Given the increasingly strong correlation between transportation, lack of
healthcare access, and patient no-shows to medical care, this project aims to study the effect of providing
subsidized rides for patients afflicted by opioid use disorder (OUD) or drug use that screen positive for a
transportation need. Roundtrip is focused on removing transportation as a barrier to access care, especially
as it pertains to substance and drug use. Roundtrip is currently partnered with some of the most reputed
national healthcare brands in the US across 20 states, including Geisinger, Johns Hopkins, the NIH, and
large behavioral health systems like Aurora Behavioral, moving patients daily that need various forms of
medical care including drug addiction and associated behavioral health issues related to opioid use. This
project seeks to measure the impact of access to timely transportation on overall clinical outcomes for the
aforementioned group of pre-identified patients, allowing partnered healthcare providers to effectively
administer medical care and prescribe medication-assisted treatment to those in need. We will determine if
the Roundtrip platform is an appropriate, scalable mechanism to promote an increased adoption of drug
treatment programs that have had well-documented success in reducing overall drug use by alleviating the
burden of transportation and the associated logistical challenges of such programs. Thus, we look to create a
scalable and data-driven mechanism that expands access to medical care for those affected by OUD and/or
drug use, with the goal of demonstrating a viable and replicable model that can be applied in communities
across the country.
抽象的
Roundtrip 的交通软件平台是一个交钥匙解决方案,将交通作为一种社会活动
通过为任何医疗保健组织提供单一接触点来协调各个级别的健康决定因素
非紧急交通(拼车、医疗轿车、轮椅车、非紧急救护车)
鉴于交通运输与缺乏专业患者群体之间的相关性越来越强。
该项目旨在研究提供医疗服务的效果
为受阿片类药物使用障碍 (OUD) 或筛查呈阳性的药物使用影响的患者提供乘车补贴
交通需求。往返的重点是消除交通作为获得护理的障碍,尤其是
Roundtrip 目前与一些最著名的公司合作。
美国 20 个州的全国性医疗保健品牌,包括 Geisinger、约翰·霍普金斯、NIH 和
像 Aurora Behavioral 这样的大型行为健康系统,每天都会转移需要各种形式的患者
医疗护理,包括毒瘾和与阿片类药物使用相关的行为健康问题。
该项目旨在衡量及时交通对总体临床结果的影响
讨论预先确定的患者群体,使合作的医疗保健提供者能够有效地
我们将确定是否向有需要的人提供医疗护理和药物辅助治疗。
Roundtrip 平台是一个适当的、可扩展的机制,可促进更多药物的采用
治疗方案在通过缓解
因此,我们希望创建一个此类计划的运输负担和相关的物流挑战。
可扩展和数据驱动的机制,扩大受 OUD 和/或影响的人获得医疗保健的机会
药物使用,目的是展示可应用于社区的可行且可复制的模式
全国各地。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brendan McNiff其他文献
Brendan McNiff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于前景理论的ADHD用药决策过程与用药依从性内在机制研究
- 批准号:72304279
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于强化学习AI聊天机器人对MSM开展PrEP服药依从性精准干预模式探索及干预效果研究
- 批准号:82373638
- 批准年份:2023
- 资助金额:59 万元
- 项目类别:面上项目
基于HAPA理论的PCI术后患者运动依从性驱动机制与干预方案构建研究
- 批准号:72304180
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于保护动机理论的新确诊青少年HIV感染者抗病毒治疗依从性“游戏+”健康教育及作用机制研究
- 批准号:82304256
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于健康行为程式模型提升高血压患者药物依从性的干预策略构建研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Adapting Online Obesity Treatment for Primary Care Patients in Poverty
为贫困初级保健患者采用在线肥胖治疗
- 批准号:
10722366 - 财政年份:2023
- 资助金额:
$ 25.21万 - 项目类别:
Promoting Viral Suppression through the CHAMPS+ Intervention in the Deep South
通过 CHAMPS 干预南部腹地促进病毒抑制
- 批准号:
10819823 - 财政年份:2023
- 资助金额:
$ 25.21万 - 项目类别:
I-TRANSFER Improving TRansitions ANd outcomeS oF sEpsis suRvivors
I-TRANSFER 改善脓毒症幸存者的转变和结果
- 批准号:
10824878 - 财政年份:2023
- 资助金额:
$ 25.21万 - 项目类别:
Implementation of collaborative care for depression in VA HIV clinics: Translating Initiatives for Depression into Effective Solutions (HITIDES)
在 VA HIV 诊所实施抑郁症协作护理:将抑郁症倡议转化为有效解决方案 (HITIDES)
- 批准号:
9837042 - 财政年份:2023
- 资助金额:
$ 25.21万 - 项目类别:
Adaptation of a Digital Health Intervention for Chronic Condition Related fatigue to the Latino population
针对拉丁裔人群慢性病相关疲劳的数字健康干预措施的适应
- 批准号:
10697435 - 财政年份:2023
- 资助金额:
$ 25.21万 - 项目类别: